Inventiva (IVA) Operating Leases (2022 - 2025)

Inventiva's (IVA) quarterly Operating Leases came in at $3.2 million in Q4 2025, up 19.78% year-on-year from $2.7 million in Q4 2024, and down 29.24% quarter-over-quarter from $4.6 million in Q2 2025.

Inventiva (IVA) Operating Leases (2022 - 2025) Analysis & Trends

Inventiva's Operating Leases history runs 4 years deep, the most recent figure standing at $3.2 million for Q4 2025.

  • On a quarterly basis, Operating Leases rose 19.78% year-over-year to $3.2 million in Q4 2025; TTM through Dec 2025 was $3.2 million, a 19.78% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 19.78% from the prior year.
  • Operating Leases retreated to $3.2 million in Q4 2025 per IVA's latest filing, from $4.6 million in the prior quarter.
  • Across five years, Operating Leases topped out at $7.1 million in Q2 2024 and bottomed at $2.7 million in Q4 2024.
  • The 4-year median for Operating Leases is $4.6 million (2023), against an average of $4.6 million.
  • Biggest YoY gain for Operating Leases was 31.64% in 2024; the steepest drop was 41.35% in 2024.
  • Year by year, Operating Leases stood at $4.6 million in 2022, then slipped by 0.22% to $4.6 million in 2023, then tumbled by 41.35% to $2.7 million in 2024, then increased by 19.78% to $3.2 million in 2025.
  • Per Business Quant, the three latest IVA Operating Leases figures stand at $3.2 million (Q4 2025), $4.6 million (Q2 2025), and $2.7 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Inventiva 842.48 Mn 842.48 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 3.23 Mn
Jun 30, 2025 4.56 Mn
Dec 31, 2024 2.69 Mn
Jun 30, 2024 7.07 Mn
Dec 31, 2023 4.59 Mn
Jun 30, 2023 5.37 Mn
Dec 31, 2022 4.60 Mn